Lanean...
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
Dipeptidyl peptidase-4 inhibitors (DPP-4is) have gained a key place in the management of type 2 diabetes mellitus (T2DM) essentially because of their good safety profile even in the frail population. DPP-4, originally known as ‘T-cell antigen CD26’, is expressed in many immune cells and regulates th...
Gorde:
| Argitaratua izan da: | Diabetes Metab |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Masson SAS.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690941/ https://ncbi.nlm.nih.gov/pubmed/33249199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diabet.2020.11.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|